CIK 1442756
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 55.81% | 43 |
| Health Care Equipment & Supplies | 15.96% | 11 |
| Health Care Providers & Services | 13.68% | 7 |
| Unclassified | 4.87% | 5 |
| Insurance | 3.90% | 4 |
| Distributors | 1.93% | 2 |
| Life Sciences Tools & Services | 1.65% | 2 |
| Professional Services | 1.42% | 1 |
| Technology Hardware & Equipment | 0.78% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | THC | TENET HEALTHCARE CORP | Health Care | 8.06% |
| 2 | LLY | ELI LILLY & Co | Health Care | 6.48% |
| 3 | PEN | Penumbra Inc | Health Care | 4.92% |
| 4 | AXSM | Axsome Therapeutics, Inc. | Health Care | 4.79% |
| 5 | ASND | Ascendis Pharma A/S | Health Care | 3.73% |
| 6 | JAZZ | Jazz Pharmaceuticals plc | Health Care | 3.61% |
| 7 | NBIX | NEUROCRINE BIOSCIENCES INC | Health Care | 3.04% |
| 8 | UTHR | UNITED THERAPEUTICS Corp | Health Care | 2.53% |
| 9 | GKOS | GLAUKOS Corp | Health Care | 2.49% |
| 10 | CENTESSA PHARMACEUTICALS PLC | Unclassified | 2.25% |
71/76 names classified · sector 95.1% of weight · industry 95.1% · mkt cap 88.9%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 95.1% of the book is sector-classified (unclassified names shown, never dropped).
Only 45% of book weight classified — the grid is NOT representative of the whole book.
Classified: 45.2% of book weight (23/74 names) · unclassified 54.8%: AXSM, , ASND, JAZZ, GKOS, INBX, BBIO, MDGL, DNTH, RVMD +41 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | THCTenet Healthcare Corp. | 398,567 | $75M | 8.1% | HOLD |
| 2 | LLYELI LILLY & CO | 65,762 | $60M | 6.5% | TRIM −4% |
| 3 | PENPENUMBRA INC | 139,779 | $46M | 4.9% | TRIM −4% |
| 4 | AXSMAXSOME THERAPEUTICS INC. | 264,304 | $45M | 4.8% | ADD 5% |
| 5 | ASNDASCENDIS PHARMA A/S | 152,034 | $35M | 3.7% | TRIM −14% |
| 6 | JAZZJAZZ PHARMACEUTICALS PLC | 178,144 | $34M | 3.6% | ADD 253% |
| 7 | NBIXNEUROCRINE BIOSCIENCES INC | 215,678 | $28M | 3.0% | ADD 32% |
| 8 | UTHRUnited Therapeutics Corp. | 39,805 | $24M | 2.5% | TRIM −41% |
| 9 | GKOSGLAUKOS CORP | 215,685 | $23M | 2.5% | ADD 7% |
| 10 | CENTESSA PHARMACEUTICALS PLC | 528,224 | $21M | 2.2% | TRIM −11% |
| 11 | INBXINHIBRX BIOSCIENCES INC | 305,431 | $21M | 2.2% | ADD 15% |
| 12 | EWEDWARDS LIFESCIENCES CORP | 254,510 | $20M | 2.2% | ADD 3% |
| 13 | BBIOBRIDGEBIO PHARMA INC | 257,747 | $19M | 2.1% | TRIM −16% |
| 14 | MDGLMADRIGAL PHARMACEUTICALS INC | 34,146 | $18M | 1.9% | ADD 370% |
| 15 | INDVINDIVIOR PHARMACEUTICALS INC COM | 574,666 | $18M | 1.9% | NEW |
| 16 | UNHUNITEDHEALTH GROUP INC | 58,038 | $16M | 1.7% | ADD 15% |
| 17 | DNTHDIANTHUS THERAPEUTICS INC | 172,137 | $14M | 1.5% | ADD 73% |
| 18 | ABTABBOTT LABS | 140,432 | $14M | 1.5% | NEW |
| 19 | RVMDREVOLUTION MEDICINES INC | 140,770 | $14M | 1.5% | TRIM −7% |
| 20 | ACHCACADIA HEALTHCARE COMPANY IN | 582,745 | $14M | 1.5% | NEW |
| 21 | NEONEOGENOMICS INC | 1,784,552 | $13M | 1.4% | ADD 5% |
| 22 | COOCOOPER COS INC | 169,829 | $12M | 1.3% | ADD 68% |
| 23 | NTRANATERA INC | 60,004 | $12M | 1.3% | NEW |
| 24 | ITGRINTEGER HLDGS CORP | 135,081 | $12M | 1.3% | ADD 27% |
| 25 | RYTMRHYTHM PHARMACEUTICALS INC | 136,621 | $12M | 1.3% | ADD 240% |
| 26 | WATWATERS CORP | 39,763 | $12M | 1.3% | TRIM −8% |
| 27 | AMRXAMNEAL PHARMACEUTICALS INC | 930,096 | $12M | 1.2% | TRIM −37% |
| 28 | PRAXPRAXIS PRECISION MEDICINES I | 35,438 | $11M | 1.2% | ADD 14% |
| 29 | HSICHENRY SCHEIN INC | 153,114 | $11M | 1.2% | NEW |
| 30 | CGONCG ONCOLOGY INC | 165,925 | $11M | 1.2% | HOLD |
| 31 | MMSIMERIT MED SYS INC | 162,469 | $11M | 1.2% | NEW |
| 32 | CLDXCELLDEX THERAPEUTICS INC NEW | 324,957 | $10M | 1.1% | ADD 144% |
| 33 | BLTEBELITE BIO INC | 59,432 | $9M | 1.0% | ADD 200% |
| 34 | DXCMDEXCOM | 149,734 | $9M | 1.0% | TRIM −34% |
| 35 | TERNS PHARMACEUTICALS INC | 172,962 | $9M | 1.0% | NEW |
| 36 | CNCCENTENE CORP DEL | 263,486 | $9M | 0.9% | TRIM −64% |
| 37 | VKTXVIKING THERAPEUTICS INC | 263,106 | $9M | 0.9% | ADD 39% |
| 38 | ORKAORUKA THERAPEUTICS INC | 174,052 | $9M | 0.9% | NEW |
| 39 | TNGXTANGO THERAPEUTICS INC | 406,245 | $8M | 0.9% | NEW |
| 40 | SOLENO THERAPEUTICS INC | 248,180 | $8M | 0.9% | HOLD |
| 41 | BTSGBRIGHTSPRING HEALTH SVCS INC | 187,335 | $8M | 0.9% | ADD 58% |
| 42 | CMPSCOMPASS PATHWAYS PLC | 1,367,099 | $8M | 0.8% | ADD 75% |
| 43 | TMOTHERMO FISHER SCIENTIFIC INC | 14,832 | $7M | 0.8% | TRIM −61% |
| 44 | NVONOVO-NORDISK A S | 197,181 | $7M | 0.8% | NEW |
| 45 | SYKSTRYKER CORPORATION | 21,957 | $7M | 0.8% | TRIM −57% |
| 46 | VERAVERA THERAPEUTICS INC | 174,867 | $7M | 0.8% | ADD 62% |
| 47 | BLLNBILLIONTOONE INC | 88,069 | $7M | 0.7% | HOLD |
| 48 | CAHCARDINAL HEALTH INC | 31,941 | $7M | 0.7% | TRIM −49% |
| 49 | ICLRICON PLC | 57,500 | $6M | 0.7% | TRIM −50% |
| 50 | ALHCALIGNMENT HEALTHCARE INC | 359,826 | $6M | 0.7% | NEW |
| 51 | HCAHCA HEALTHCARE INC | 13,351 | $6M | 0.7% | TRIM −4% |
| 52 | GPCRSTRUCTURE THERAPEUTICS INC | 126,383 | $6M | 0.7% | ADD 85% |
| 53 | ROIVROIVANT SCIENCES LTD | 207,446 | $6M | 0.6% | NEW |
| 54 | OSCROSCAR HEALTH INC | 499,837 | $6M | 0.6% | HOLD |
| 55 | SNDXSYNDAX PHARMACEUTICALS INC | 245,021 | $6M | 0.6% | HOLD |
| 56 | TARSTARSUS PHARMACEUTICALS INC | 80,226 | $6M | 0.6% | ADD 193% |
| 57 | PSNLPERSONALIS INC | 870,097 | $6M | 0.6% | ADD 8% |
| 58 | KODKODIAK SCIENCES INC | 114,719 | $4M | 0.5% | NEW |
| 59 | ARWRARROWHEAD PHARMACEUTICALS IN | 64,279 | $4M | 0.4% | NEW |
| 60 | EPRXEupraxia Pharmaceuticals Inc | 540,871 | $4M | 0.4% | NEW |
| 61 | DFTXDEFINIUM THERAPEUTICS INC COM SHS | 205,317 | $4M | 0.4% | NEW |
| 62 | MLYSMINERALYS THERAPEUTICS INC | 142,677 | $4M | 0.4% | ADD 200% |
| 63 | MDLNMEDLINE INC | 86,777 | $4M | 0.4% | ADD 2% |
| 64 | CAPRCAPRICOR THERAPEUTICS INC | 123,831 | $4M | 0.4% | NEW |
| 65 | ILMNILLUMINA INC | 28,869 | $4M | 0.4% | NEW |
| 66 | ARGXARGENX SE | 4,535 | $3M | 0.4% | ADD 8% |
| 67 | CGEMCULLINAN THERAPEUTICS INC | 227,406 | $3M | 0.3% | HOLD |
| 68 | ABVXABIVAX SA | 26,664 | $3M | 0.3% | TRIM −16% |
| 69 | OMOUTSET MED INC | 594,630 | $2M | 0.2% | ADD 12% |
| 70 | MBXMBX BIOSCIENCES INC | 71,894 | $2M | 0.2% | TRIM −9% |
| 71 | AMLXAMYLYX PHARMACEUTICALS INC | 145,275 | $2M | 0.2% | ADD 8% |
| 72 | CRBUCARIBOU BIOSCIENCES INC | 957,787 | $2M | 0.2% | HOLD |
| 73 | GMEDGLOBUS MED INC | 16,923 | $1M | 0.2% | NEW |
| 74 | TECXTECTONIC THERAPEUTIC INC | 46,129 | $1M | 0.2% | ADD 8% |
| 75 | QUREUNIQURE NV | 42,635 | $697,082 | 0.1% | ADD 8% |
| 76 | RZLTREZOLUTE INC | 128,726 | $392,614 | 0.0% | TRIM −38% |
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| THCTenet Healthcare Corp. | 491K | 491K | 499K | 462K | 398K | 399K | $75M |
| LLYELI LILLY & CO | 299K | 274K | 268K | 225K | 68K | 66K | $60M |
| PENPENUMBRA INC | 166K | 166K | 166K | 195K | 145K | 140K | $46M |
| AXSMAXSOME THERAPEUTICS INC. | 467K | 557K | 483K | 530K | 252K | 264K | $45M |
| ASNDASCENDIS PHARMA A/S | 52K | 187K | 222K | 145K | 178K | 152K | $35M |
| JAZZJAZZ PHARMACEUTICALS PLC | 18K | — | — | — | 51K | 178K | $34M |
| NBIXNEUROCRINE BIOSCIENCES INC | 167K | — | 13K | 57K | 163K | 216K | $28M |
| UTHRUnited Therapeutics Corp. | 53K | — | 36K | 96K | 68K | 40K | $24M |
| GKOSGLAUKOS CORP | — | — | — | — | 202K | 216K | $23M |
| CENTESSA PHARMACEUTICALS PLC | 372K | 571K | 345K | 666K | 592K | 528K | $21M |
| INBXINHIBRX BIOSCIENCES INC | 136K | 439K | 244K | 240K | 266K | 305K | $21M |
| EWEDWARDS LIFESCIENCES CORP | 594K | 380K | 393K | 381K | 247K | 255K | $20M |
| BBIOBRIDGEBIO PHARMA INC | 290K | 908K | 522K | 327K | 307K | 258K | $19M |
| MDGLMADRIGAL PHARMACEUTICALS INC | — | — | — | — | 7K | 34K | $18M |
| INDVINDIVIOR PHARMACEUTICALS INC COM | — | — | — | — | — | 575K | $18M |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
